Cargando…
An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering
The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly p...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541411/ https://www.ncbi.nlm.nih.gov/pubmed/37773238 http://dx.doi.org/10.1038/s41467-023-41821-6 |
_version_ | 1785113899772674048 |
---|---|
author | Cui, Gaofeng Botuyan, Maria Victoria Drané, Pascal Hu, Qi Bragantini, Benoît Thompson, James R. Schuller, David J. Detappe, Alexandre Perfetti, Michael T. James, Lindsey I. Frye, Stephen V. Chowdhury, Dipanjan Mer, Georges |
author_facet | Cui, Gaofeng Botuyan, Maria Victoria Drané, Pascal Hu, Qi Bragantini, Benoît Thompson, James R. Schuller, David J. Detappe, Alexandre Perfetti, Michael T. James, Lindsey I. Frye, Stephen V. Chowdhury, Dipanjan Mer, Georges |
author_sort | Cui, Gaofeng |
collection | PubMed |
description | The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly populated closed state of 53BP1 in which the H4K20me2 binding surface is buried at the interface between two interacting 53BP1 molecules. In cells, these antagonists inhibit the chromatin recruitment of wild type 53BP1, but do not affect 53BP1 variants unable to access the closed conformation despite preservation of the H4K20me2 binding site. Thus, this inhibition operates by shifting the conformational equilibrium toward the closed state. Our work therefore identifies an auto-associated form of 53BP1—autoinhibited for chromatin binding—that can be stabilized by small molecule ligands encapsulated between two 53BP1 protomers. Such ligands are valuable research tools to study the function of 53BP1 and have the potential to facilitate the development of new drugs for cancer therapy. |
format | Online Article Text |
id | pubmed-10541411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-105414112023-10-01 An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering Cui, Gaofeng Botuyan, Maria Victoria Drané, Pascal Hu, Qi Bragantini, Benoît Thompson, James R. Schuller, David J. Detappe, Alexandre Perfetti, Michael T. James, Lindsey I. Frye, Stephen V. Chowdhury, Dipanjan Mer, Georges Nat Commun Article The recruitment of 53BP1 to chromatin, mediated by its recognition of histone H4 dimethylated at lysine 20 (H4K20me2), is important for DNA double-strand break repair. Using a series of small molecule antagonists, we demonstrate a conformational equilibrium between an open and a pre-existing lowly populated closed state of 53BP1 in which the H4K20me2 binding surface is buried at the interface between two interacting 53BP1 molecules. In cells, these antagonists inhibit the chromatin recruitment of wild type 53BP1, but do not affect 53BP1 variants unable to access the closed conformation despite preservation of the H4K20me2 binding site. Thus, this inhibition operates by shifting the conformational equilibrium toward the closed state. Our work therefore identifies an auto-associated form of 53BP1—autoinhibited for chromatin binding—that can be stabilized by small molecule ligands encapsulated between two 53BP1 protomers. Such ligands are valuable research tools to study the function of 53BP1 and have the potential to facilitate the development of new drugs for cancer therapy. Nature Publishing Group UK 2023-09-29 /pmc/articles/PMC10541411/ /pubmed/37773238 http://dx.doi.org/10.1038/s41467-023-41821-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Cui, Gaofeng Botuyan, Maria Victoria Drané, Pascal Hu, Qi Bragantini, Benoît Thompson, James R. Schuller, David J. Detappe, Alexandre Perfetti, Michael T. James, Lindsey I. Frye, Stephen V. Chowdhury, Dipanjan Mer, Georges An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering |
title | An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering |
title_full | An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering |
title_fullStr | An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering |
title_full_unstemmed | An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering |
title_short | An autoinhibited state of 53BP1 revealed by small molecule antagonists and protein engineering |
title_sort | autoinhibited state of 53bp1 revealed by small molecule antagonists and protein engineering |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10541411/ https://www.ncbi.nlm.nih.gov/pubmed/37773238 http://dx.doi.org/10.1038/s41467-023-41821-6 |
work_keys_str_mv | AT cuigaofeng anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT botuyanmariavictoria anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT dranepascal anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT huqi anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT bragantinibenoit anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT thompsonjamesr anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT schullerdavidj anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT detappealexandre anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT perfettimichaelt anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT jameslindseyi anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT fryestephenv anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT chowdhurydipanjan anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT mergeorges anautoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT cuigaofeng autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT botuyanmariavictoria autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT dranepascal autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT huqi autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT bragantinibenoit autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT thompsonjamesr autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT schullerdavidj autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT detappealexandre autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT perfettimichaelt autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT jameslindseyi autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT fryestephenv autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT chowdhurydipanjan autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering AT mergeorges autoinhibitedstateof53bp1revealedbysmallmoleculeantagonistsandproteinengineering |